Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt repayments
Ratios

China Pharma Holdings (CPHI) Long-Term Debt Issuances (2016 - 2025)

Historic Long-Term Debt Issuances for China Pharma Holdings (CPHI) over the last 14 years, with Q3 2025 value amounting to -$44176.0.

  • China Pharma Holdings' Long-Term Debt Issuances fell 74556.48% to -$44176.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $260299.0, marking a year-over-year increase of 84667.95%. This contributed to the annual value of $27353.0 for FY2024, which is 1052.92% down from last year.
  • As of Q3 2025, China Pharma Holdings' Long-Term Debt Issuances stood at -$44176.0, which was down 74556.48% from $290886.0 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Long-Term Debt Issuances high stood at $932114.0 for Q3 2022, and its period low was -$3.7 million during Q4 2021.
  • For the 5-year period, China Pharma Holdings' Long-Term Debt Issuances averaged around -$129569.0, with its median value being $6852.0 (2024).
  • As far as peak fluctuations go, China Pharma Holdings' Long-Term Debt Issuances plummeted by 835290.29% in 2021, and later soared by 414527.15% in 2025.
  • Quarter analysis of 5 years shows China Pharma Holdings' Long-Term Debt Issuances stood at -$3.7 million in 2021, then skyrocketed by 100.19% to $6848.0 in 2022, then rose by 1.42% to $6945.0 in 2023, then decreased by 2.06% to $6802.0 in 2024, then tumbled by 749.46% to -$44176.0 in 2025.
  • Its Long-Term Debt Issuances was -$44176.0 in Q3 2025, compared to $290886.0 in Q2 2025 and $6787.0 in Q1 2025.